Article Text

other Versions

Aneurysm Occlusion in Elderly Patients with Aneurysmal Subarachnoid Hemorrhage: A Cost-Utility Analysis
  1. Hendrik Koffijberg1,*,
  2. Gabriel J.E. Rinkel1,
  3. Erik Buskens2
  1. 1 University Medical Center Utrecht, Netherlands;
  2. 2 University Medical Center Groningen, Netherlands
  1. Correspondence to: Hendrik Koffijberg, Julius Center, University Medical Center Utrecht, P.O. Box 85500, Utrecht, 3508 GA, Netherlands; h.koffijberg{at}


Background: Aneurysm occlusion after subarachnoid hemorrhage (SAH) aims to improve outcome by reducing the rebleeding risk. With increasing age overall prognosis decreases and the complications of aneurysm occlusion increase. The balance of risks for aneurysm occlusion in elderly SAH patients in different age categories and clinical conditions is unknown.

Methods: A Markov model was used to evaluate quality-adjusted life years (QALY), additional costs, and incremental cost-effectiveness ratios (ICER) of aneurysm occlusion in 192 patient subgroups, based on age, gender, neurological condition at admission, time since SAH, and aneurysm size and location. Probabilistic sensitivity analyses were performed.

Results: For patients admitted in poor condition ≥10 days after SAH, and patients older than 80 year, admitted in poor condition admitted ≥4 days after SAH, occlusion implied QALY loss and increased costs. Only for women younger than 79 and men younger than 74 years admitted in good condition within 4 days the ICER of occlusion fell below € 50,000 per QALY. Occlusion was beneficial and cost-saving in women aged 74 years or younger admitted in good condition within 4 days and a small posterior circulation aneurysm.

Conclusions: Aneurysm occlusion is harmful in some subgroups of elderly patients and beneficial in others. It is cost-effective only in specific subgroups that comprise a large part of the patients encountered in clinical practice. Beyond the age of 80 years the balance between risks and benefits is often no longer positive for occlusion, and it should only be considered if the predicted life expectancy leaves margin for benefit.

Statistics from


    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.